Global Human Milk Oligosaccharides (HMO) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.

Scope of the Report:
The worldwide market for Human Milk Oligosaccharides (HMO) is expected to grow at a CAGR of roughly 27.1% over the next five years, will reach 450 million US$ in 2024, from 110 million US$ in 2019, according to a new study.
This report focuses on the Human Milk Oligosaccharides (HMO) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Abbott
Inbiose
Company two
Jennewein Biotechnologie
Glycom
ZuChem
Dextra Laboratories

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Neutral
Acidic

Market Segment by Applications, can be divided into
Food Industry
Laboratory Research

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Milk Oligosaccharides (HMO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Milk Oligosaccharides (HMO), with price, sales, revenue and global market share of Human Milk Oligosaccharides (HMO) in 2017 and 2018.
Chapter 3, the Human Milk Oligosaccharides (HMO) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Milk Oligosaccharides (HMO) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Human Milk Oligosaccharides (HMO) sales channel, distributors, customers, research findings and conclusion, appendix and data source.